A high-risk challenging PDA device closure: Closing the window percutaneously in a sick infant

Abstract

Background: Patent ductus arteriosus (PDA) in symptomatic infants often leads to failure to thrive and recurrent lower respiratory tract infections (LRTI). While surgical ligation was traditionally the gold standard for small, sick infants, percutaneous device closure. While surgical ligation was traditionally the gold standard for small, sick infants, percutaneous device closure is increasingly performed as a less invasive alternative, despite significant technical challenges in low-weight patients.